Home » Topics » BioWorld Science

BioWorld Science
RSS

AutoVac vaccines designed for inflammatory and bone diseases

June 22, 2004

Boehringer Ingelheim presents novel xanthine-based DPP-IV inhibitors

June 22, 2004

New antiviral agents prepared and tested at Bayer

June 22, 2004

Further preclinical data on antirheumatic disease activity of AGIX-4207

June 22, 2004

FDA accepts Genmab IND for phase I/II study of HuMax-CD20 in CLL

June 22, 2004

Guilford licenses U.S. rights to GPI-1485 to Symphony Neuro Development Company

June 22, 2004

Enrollment complete in phase IIa trial of DG-031 for heart attack prevention

June 22, 2004

IPL-512602 fails to meet primary endpoint in asthma study

June 22, 2004

Prosidion to acquire DPP-IV platform from Probiodrug

June 22, 2004

PRDT's ligand technology binds and removes viruses from blood product

June 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.